Today: 30 April 2026
GE Vernova stock jumps 6% as Trump-backed PJM power auction plan targets AI data-center demand

GE Vernova stock jumps 6% as Trump-backed PJM power auction plan targets AI data-center demand

NEW YORK, Jan 16, 2026, 13:14 ET — Regular session

  • Shares of GE Vernova climbed after Washington unveiled a power-market proposal linked to AI data centers
  • Power producers fall as investors consider how accelerated new generation might impact prices
  • Next on deck: updates from PJM and regulators, followed by GE Vernova’s earnings and outlook for Jan. 28

Shares of GE Vernova Inc (GEV) jumped over 6% on Friday following reports that the Trump administration, along with several governors, is pushing for an emergency power auction in the PJM market. Investors took the move as a potential boost for turbine demand. By 12:58 p.m. ET, the stock had climbed 6.1% to $681.57, hitting an intraday peak of $692.49 earlier.

The shift thrust the power-equipment maker into a battle that’s gripped U.S. markets for months: who will build the next generation wave—and who will foot the bill—as data centers expand.

For GE Vernova, the immediate connection is clear. When policymakers accelerate new power-plant projects, turbine manufacturers and grid equipment suppliers typically see orders come in sooner.

Electricity stocks diverged sharply. Constellation Energy tumbled roughly 10%, Vistra slipped around 6%, and Talen Energy dropped close to 9%. The S&P 500, meanwhile, barely budged.

The White House and governors from PJM states are pushing the grid operator to hold a one-time “reliability” auction, a type of capacity auction that pays generators to stay available. Data-center owners would bid for 15-year contracts, potentially backing about $15 billion in new power plants, according to a White House official. They want PJM to run the auction by the end of September, just before PJM’s Monday deadline to respond to the Federal Energy Regulatory Commission. Joe Bowring, president of Monitoring Analytics, PJM’s independent watchdog, called it “a significant improvement,” while ClearView Energy Partners’ Timothy Fox said political pressure alone is “very likely to motivate a considerable response” even without a legal mandate. TribLIVE.com

The White House presented the move as a win for consumers. Spokeswoman Taylor Rogers described it as delivering “much-needed, long-term relief” to the mid-Atlantic region. PJM spokesperson Jeff Shields noted the grid operator wasn’t invited to the White House event and wouldn’t be attending. ABC News

The policy route remains complicated. PJM must sign off on any new auction rules, and FERC approval often takes time. Plus, constructing big gas plants faces hurdles like permits, supply-chain issues, and interconnection delays. If demand forecasts weaken or the market senses oversupply, the “AI power” boost for equipment stocks could vanish quickly.

GE Vernova has emerged as a key player in that space, offering large gas turbines, related services, and electrification equipment that helps deliver power to the grid. Friday’s trading illustrated just how reactive the stock is to news out of Washington and grid operators, beyond the company’s core fundamentals.

GE Vernova’s fourth-quarter earnings drop on Jan. 28 marks the next big event, with CEO Scott Strazik and CFO Ken Parks set to present during a 7:30 a.m. EST webcast. Investors will focus on any fresh details about orders, pricing trends, and how quickly new generation projects are ramping up.

Stock Market Today

  • Biogen Shares Rise 6% After Q1 Earnings Beat Despite Guidance Cut
    April 29, 2026, 9:29 PM EDT. Biogen (NASDAQ: BIIB) shares rose 6% on Wednesday following its first-quarter 2026 earnings report. The biotech posted $2.48 billion in revenue, surpassing analyst expectations of $2.25 billion. Net income, excluding accounting standards (GAAP), increased 19% to over $529 million, or $3.57 per share, above forecasts of $2.95. Growth was driven by strong sales of Leqembi, for early Alzheimer's, up 74%, and the FDA-approved Skyclarys for Friedreich's ataxia. However, Biogen cut full-year adjusted net income guidance by $1 per share citing research and development charges. Revenue is expected to decline mid-single digits from 2025, excluding a pending $5.6 billion acquisition of Apellis Pharmaceuticals. Biogen's strategic shift towards high-potential therapies is underway despite cautious outlook.

Latest article

Soluna Holdings Stock Jumps After Sazmining Bitcoin Deal, Then SEC Resale Filing Lands

Soluna Holdings Stock Jumps After Sazmining Bitcoin Deal, Then SEC Resale Filing Lands

30 April 2026
Soluna Holdings filed to register the resale of about 2.46 million common shares, with no proceeds going to the company. The move follows Sazmining’s launch of a 3-megawatt Bitcoin mining operation at Soluna’s Project Dorothy 1B in West Texas. Soluna shares last traded at $1.28, up from a $1.08 Nasdaq sale price on April 28. The registered shares include 2.4 million issuable to YA II PN, LTD. via warrant exercise.
Brookfield Renewable Stock Drops 12% Before Q1 Results as BEPC Investors Brace for Friday

Brookfield Renewable Stock Drops 12% Before Q1 Results as BEPC Investors Brace for Friday

30 April 2026
Brookfield Renewable Corp’s NYSE shares fell 12.5% to $35.20 on Wednesday, with volume quadrupling the three-month average ahead of first-quarter results due Friday. The drop came despite a higher quarterly dividend and mixed analyst views. The company operates 47 GW of clean energy assets globally. Analysts expect a first-quarter loss of 33.92 cents per share on $1.62 billion in revenue.
Navitas Semiconductor stock jumps with chip sector as AI data-center power trade stays in play
Previous Story

Navitas Semiconductor stock jumps with chip sector as AI data-center power trade stays in play

Eaton stock jumps on HSBC upgrade as data-center power demand grabs the tape
Next Story

Eaton stock jumps on HSBC upgrade as data-center power demand grabs the tape

Go toTop